CAS 2319722-40-0

Formule : C17H17Cl2N3O2

InChI : InChI=1S/C17H15N3O2.2ClH/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11;;/h2-5,7-8H,6,9,18H2,1H3;2*1H

Code InChI : NDRITPLSHUPVRR-UHFFFAOYSA-N

SMILES : CC1=NN=C(C2=CC3=C(C=C2C1)OCO3)C4=CC=C(C=C4)N.Cl.Cl

GYKI 52466 dihydrochloride

CAS : 2319722-40-0

GYKI 52466 dihydrochloride

Formule : C₁₇H₁₇Cl₂N₃O₂

Degré de pureté : 99%

Masse moléculaire : 366.24

Ref: 54-BUP21871

GYKI 52466 dihydrochloride

CAS : 2319722-40-0

GYKI 52466 dihydrochloride is an AMPA/Kainate receptor antagonist with anticonvulsant activity and can be used to study neurological diseases.

Formule : C₁₇H₁₇Cl₂N₃O₂

Degré de pureté : 99.38%

Couleur et forme : Yellow Solid

Masse moléculaire : 366.24

Ref: TM-T11522

GYKI 52466 (dihydrochloride)

CAS : 2319722-40-0

Formule : C₁₇H₁₇Cl₂N₃O₂

Degré de pureté : 99.38%

Masse moléculaire : 366.2418

Ref: IN-DA01LPZ3

GYKI 52466 dihydrochloride

CAS : 2319722-40-0

GYKI 52466 dihydrochloride is a benzodiazepine that binds to the gamma-aminobutyric acid (GABA) receptor, which is an inhibitory neurotransmitter. It has a binding affinity for the alpha 1 subunit of the GABA receptor, which is found in all parts of the brain and spinal cord. GYKI 52466 dihydrochloride blocks the binding of benzodiazepine to GABA receptors, thereby increasing the activity of neurons in the central nervous system. This drug also has antitumor properties, as it may work by inhibiting tumor growth and inducing cell death. GYKI 52466 dihydrochloride may have onsets ranging from hours to days, depending on how quickly it reaches therapeutic levels in the body.

Formule : C₁₇H₁₇Cl₂N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 366.2 g/mol

Ref: 3D-USD72240